Search results for: HTA
Filter search results
Valuing Co-Dependent Medical Technologies: Improving Methods and Processes
23 April 2013
Advances in science and technology are producing more and better means for diagnosing disease, matching patients to the best therapies, and tracking the progress of treatment. The potential impact of…
Spotlight on OHE: Opportunity Costs of NICE Decisions in Wales and HESG 2015
20 January 2015
Jon Sussex presents on the opportunity costs of implementing NICE decisions in Wales, and OHE attend HESG in Leeds, January 2015. Opportunity costs of implementing NICE decisions in NHS Wales…
OHE Welcomes Dr. Aslam Anis
28 January 2015
Dr. Aslam Anis, Director of the Centre for Health Evaluation and Outcomes Sciences (CHEOS) in Canada will undertake a short sabbatical with the Office of Health Economics in February 2015….
A Framework for Payer Assessment of the Value of New Technologies: A US Approach
10 March 2015
Dr Steven Pearson has convened a US policy workgroup of payers, drug and device manufacturers, patients’ groups, and clinician specialty societies to help develop a “value framework”. Payers in the…
OHE at ISPOR Philadelphia: Presentations and Posters
4 June 2015
This blog contains a selection of the posters and presentations given by OHE at ISPOR Philadelphia in May 2015. A selection of the posters and presentations delivered by OHE at…
Patient-reported outcomes measures (PROMs) in Health Economics – an Overview and Key Developments in the Field
30 June 2015
In June 2015 OHE’s Nancy Devlin gave a seminar at the Royal Statistical Society on the topic of patient-reported outcomes measures (PROMs) in health economics – providing an overview and…
Guest post: The Economics of Elevated Hospital Mortality at Weekends
14 July 2015
Rachel Meacock reports on the economics of elevated hospital mortality at weekends. On 11th June Professor Matt Sutton of The University of Manchester presented an OHE lunchtime seminar on the…
Spotlight on OHE: Value Footprint of Oncology Treatments, Treating Obstructive Sleep Apnoea and Sources of Motivation in Health Care Organisations
4 August 2015
The blog provides links to slide sets and posters relating to the value footprint of oncology treatments, treating obstructive sleep apnoea and sources of motivation in health care organisations. Speaking…
Incorporating Life-cycle Price Modelling into Pharmaceutical Cost-effectiveness Evaluations
25 August 2015
A Research Paper on the topic of incorporating life-cycle price modelling into pharmaceutical cost-effectiveness evaluations has just been published by OHE. Why might the launch price of a new drug…